MANCINA, ROSELLINA MARGHERITA
 Distribuzione geografica
Continente #
AS - Asia 60
EU - Europa 9
NA - Nord America 5
SA - Sud America 2
Totale 76
Nazione #
SG - Singapore 54
US - Stati Uniti d'America 5
CH - Svizzera 2
IE - Irlanda 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
BD - Bangladesh 1
CN - Cina 1
EC - Ecuador 1
GR - Grecia 1
IT - Italia 1
KG - Kirghizistan 1
PE - Perù 1
PL - Polonia 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
TR - Turchia 1
Totale 76
Città #
Singapore 34
Dublin 2
Zurich 2
Antalya 1
Ashburn 1
Athens 1
Bishkek 1
Bratislava 1
Dhaka 1
Dubai 1
Guayaquil 1
Lima 1
Riyadh 1
Rome 1
Santa Clara 1
Tirana 1
Totale 51
Nome #
DEPDC5 variants increase fibrosis progression in Europeans with chronic hepatitis C virus infection 3
The IRS1 rs2943641 Variant and Risk of Future Cancer Among Morbidly Obese Individuals 3
Satisfaction in Social Roles and Physical Function in Immune-mediated Inflammatory Diseases: A Cross-Sectional Study 3
Development and Validation of a Score for Fibrotic Nonalcoholic Steatohepatitis 3
An Integrated Understanding of the Rapid Metabolic Benefits of a Carbohydrate-Restricted Diet on Hepatic Steatosis in Humans 3
Recombinant PNPLA3 protein shows triglyceride hydrolase activity and its I148M mutation results in loss of function 3
Cross talk between liver and adipose tissue: A new role for PNPLA3? 3
Mitochondrial amidoxime-reducing component 1 p.Ala165Thr increases protein degradation mediated by the proteasome 3
Beta-glucan, inositol and digestive enzymes improve quality of life of patients with inflammatory bowel disease and irritable bowel syndrome 3
Validation of Interleukin-32 as a new circulating fatty liver biomarker 3
Statin use and non-alcoholic steatohepatitis in at risk individuals 3
Virtual genetic diagnosis for familial hypercholesterolemia powered by machine learning 3
PNPLA3 has retinyl-palmitate lipase activity in human hepatic stellate cells 3
Macrophage scavenger receptor 1 mediates lipid-induced inflammation in non-alcoholic fatty liver disease 3
Effects of listening to music in digestive endoscopy: A prospective intervention study led by nursing 3
Liver transcriptomics highlights interleukin-32 as novel NAFLD-related cytokine and candidate biomarker 3
PNPLA3 148M Carriers with Inflammatory Bowel Diseases Have Higher Susceptibility to Hepatic Steatosis and Higher Liver Enzymes 3
PNPLA3 overexpression results in reduction of proteins predisposing to fibrosis 3
Gastrointestinal Symptoms of and Psychosocial Changes in Inflammatory Bowel Disease: A Nursing-Led Cross-Sectional Study of Patients in Clinical Remission 3
A two gene-based risk score predicts alcoholic cirrhosis development in males with at-risk alcohol consumption 3
Natural Extracts as Modifiers of Intracellular Lipid Handling 3
Individuals with familial hypercholesterolemia and cardiovascular events have higher circulating Lp(a) levels 2
PNPLA3 I148M polymorphism and progressive liver disease 2
Pnpla3 silencing with antisense oligonucleotides ameliorates nonalcoholic steatohepatitis and fibrosis in Pnpla3 I148M knock-in mice 2
Protein phosphatase 1 regulatory subunit 3B gene variation protects against hepatic fat accumulation and fibrosis in individuals at high risk of nonalcoholic fatty liver disease 2
Rare ATG7 genetic variants predispose patients to severe fatty liver disease 2
Deregulation of SGK1 in Ulcerative Colitis: A Paradoxical Relationship Between Immune Cells and Colonic Epithelial Cells 2
Cellular Genome-Scale Metabolic Modeling Identifies New Potential Drug Targets Against Hepatocellular Carcinoma 2
Ulcerative Colitis as an Independent Risk Factor for Hepatic Steatosis 2
Molecular analysis of three known and one novel LPL variants in patients with type I hyperlipoproteinemia 2
The rs2294918 E434K variant modulates patatin‐like phospholipase domain‐containing 3 expression and liver damage 2
PCSK7 gene variation bridges atherogenic dyslipidemia with hepatic inflammation in NAFLD patients 2
Phytomedicines to Target Hepatitis B Virus DNA Replication: Current Limitations and Future Approaches 2
PNPLA3 I148M Variant Influences Circulating Retinol in Adults with Nonalcoholic Fatty Liver Disease or Obesity 2
Accuracy of controlled attenuation parameter for assessing liver steatosis in individuals with morbid obesity before bariatric surgery 2
Exome-Wide Association Study on Alanine Aminotransferase Identifies Sequence Variants in the GPAM and APOE Associated With Fatty Liver Disease 2
ANGPTL3 Downregulation Increases Intracellular Lipids by Reducing Energy Utilization 2
Effects of PNPLA3 I148M on hepatic lipid and very-low-density lipoprotein metabolism in humans 2
Causal relationship of hepatic fat with liver damage and insulin resistance in nonalcoholic fatty liver 2
High prevalence of genetic determined familial hypercholesterolemia in premature coronary artery disease 2
Effects of TM6SF2 E167K on hepatic lipid and very low-density lipoprotein metabolism in humans 2
PNPLA3 I148M (rs738409) genetic variant is associated with hepatocellular carcinoma in obese individuals 2
IL32 downregulation lowers triglycerides and type I collagen in di-lineage human primary liver organoids 2
The TM6SF2 E167K genetic variant induces lipid biosynthesis and reduces apolipoprotein B secretion in human hepatic 3D spheroids 2
ANGPTL4 gene E40K variation protects against obesity‐associated dyslipidemia in participants with obesity 2
Paradoxical dissociation between hepatic fat content and de novo lipogenesis due to PNPLA3 sequence variant 2
Transmembrane-6 superfamily member 2 (TM6SF2) E167K variant increases susceptibility to hepatic steatosis in obese children 2
Genetic diagnosis of familial hypercholesterolaemia by targeted next‐generation sequencing 2
Patatin-like phospholipase domain-containing 3 (PNPLA3) I148M (rs738409) affects hepatic VLDL secretion in humans and in vitro 2
Transmembrane 6 superfamily member 2 gene E167K variant impacts on steatosis and liver damage in chronic hepatitis C patients 2
Adverse effects of fructose on cardiometabolic risk factors and hepatic lipid metabolism in subjects with abdominal obesity 2
PSD3 downregulation confers protection against fatty liver disease 2
PCSK9 rs11591147 R46L loss-of-function variant protects against liver damage in individuals with non-alcoholic fatty liver 2
Genetic variants in the MTHFR are not associated with fatty liver disease 2
Generation and validation of a classification model to diagnose familial hypercholesterolaemia in adults 2
Genetic Susceptibility to Chronic Liver Disease in Individuals from Pakistan 1
The COBLL1 C allele is associated with lower serum insulin levels and lower insulin resistance in overweight and obese children 1
Telomerase reverse transcriptase germline mutations and hepatocellular carcinoma in patients with nonalcoholic fatty liver disease 1
LPIAT1/MBOAT7 depletion increases triglyceride synthesis fueled by high phosphatidylinositol turnover 1
MBOAT7 is anchored to endomembranes by six transmembrane domains 1
New Diagnostic and Prognostic Models for the Development of Alcoholic Cirrhosis Based on Genetic Predisposition and Alcohol History 1
The MBOAT7-TMC4 Variant rs641738 Increases Risk of Nonalcoholic Fatty Liver Disease in Individuals of European Descent 1
MBOAT7 rs641738 variant and hepatocellular carcinoma in non-cirrhotic individuals 1
PCSK9 rs11591147 R46L Loss-of-Function Variant Protects Against Liver Damage in Individuals with NAFLD 1
Identification and characterization of two novel mutations in the LPL gene causing type I hyperlipoproteinemia 1
Totale 141
Categoria #
all - tutte 3.920
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.920


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202467 0 0 0 0 0 0 0 0 30 36 0 1
2024/202574 19 55 0 0 0 0 0 0 0 0 0 0
Totale 141